Anticoagulant therapy in catheter ablation of atrial fibrillation and flutter

Anticoagulant therapy in catheter ablation of atrial fibrillation and flutter

Catheter ablation (CA) of atrial fibrillation and flutter is associated with a high risk of both perioperative thromboembolic events and bleeding. Adequate anticoagulation is imperative to reduce the risk of complications. The aim of this review was to analyze modern approaches to anticoagulant ther...

Full description

Bibliographic Details
Main Authors:	M. V. Serova, D. A. Andreev, M. I. Chashkina, Z. K. Salpagarova
Format:	Article
Language:	Russian
Published:	«SILICEA-POLIGRAF» LLC 2021-09-01
Series:	Кардиоваскулярная терапия и профилактика
Subjects:	atrial fibrillation catheter ablation atrial flutter anticoagulant therapy perioperative management
Online Access:	https://cardiovascular.elpub.ru/jour/article/view/2974

Similar Items

Temporal trends of catheter ablation procedures in patients with atrial fibrillation and atrial flutter: A nationwide cohort study
by: Antti Lappalainen, et al.
Published: (2024-12-01)

Real‐world clinical practice of current periprocedural anticoagulation management in catheter ablation of atrial fibrillation: Data from a large prospective ablation registry
by: Yuta Taomoto, et al.
Published: (2025-02-01)

Editorial: Atrial fibrillation: insights on mechanisms, mapping and catheter ablation
by: Sergio Conti, et al.
Published: (2023-09-01)

Radiofrequency catheter ablation for pulmonary hypertension patients with atrial flutter
by: Aikai Zhang, et al.
Published: (2024-04-01)

Comparative Effectiveness of Various Radiofrequency Ablation Catheters in the Ablation of Typical Atrial Flutter
by: Asher Gorantla, et al.
Published: (2023-10-01)

10 years trends in use of oral anticoagulants in patients undergoing catheter ablation for atrial fibrillation
by: Letícia Kazareczki, et al.
Published: (2024-04-01)

The anticoagulation one year after ablation of atrial fibrillation in patients with atrial fibrillation (ALONE-AF) trial: Study protocol
by: Daehoon Kim, et al.
Published: (2024-08-01)

Association of typical atrial flutter and cavotricuspid isthmus ablation on clinical recurrence after cryoballoon ablation for atrial fibrillation
by: Joo Hee Jeong, et al.
Published: (2023-12-01)

Anteroposterior Diameter of the Left Atrium Determines the Occurrence of Left Atrial Tachycardia in Non-paroxysmal Atrial Fibrillation Patients after Catheter Ablation
by: Dicky Armein Hanafy, et al.
Published: (2024-09-01)

Risk and Protective Factors of Recurrence after Catheter Ablation for Atrial Fibrillation
by: Xinwei Guo, et al.
Published: (2024-03-01)

POSSIBILITY OF NOVEL ORAL ANTICOAGULANTS USAGE DURING ABLATION IN ATRIAL FIBRILLATION
by: B. A. Tatarsky, et al.
Published: (2014-12-01)

Cavutilide (Refralon) for pharmacological cardioversion of early recurrence atrial fibrillation and flutter in blanking period after pulmonary veins isolation
by: M. A. Zelberg, et al.
Published: (2024-05-01)

Catheter ablation of typical right atrial flutter in a 20‐day‐old neonate with tachycardiomyopathy
by: Tiago Luiz Luz Leiria, et al.
Published: (2024-02-01)

Cavotricuspid Isthmus-Dependent Atrial Flutter. Beyond Simple Linear Ablation
by: Julian Abdala-Lizarraga, et al.
Published: (2024-01-01)

ATRIAL FIBRILLATION CATHETER ABLATION: YESTERDAY, TODAY, TOMORROW
by: D. S. Lebedev
Published: (2019-02-01)

Catheter Ablation for the Management of Atrial Fibrillation: An Update of the Literature
by: Shahana Hussain, et al.
Published: (2023-08-01)

Real world risk of discontinuing oral anticoagulation after successful catheter ablation for atrial fibrillation
by: Zhen-Tao Fei, et al.
Published: (2024-06-01)

Predictors of thrombosis of left atrium and its appendage before catheter ablation or cardioversion in patients with non-valvular atrial fibrillation or atrial flutter
by: I. A. Zaigraev, et al.
Published: (2023-01-01)

Comparative Safety and Effectiveness of Sotalol Versus Dronedarone After Catheter Ablation for Atrial Fibrillation
by: John Marcus Wharton, et al.
Published: (2022-02-01)

Radiofrequency atrial flutter and atrial fibrillation ablation in a patient with deep brain stimulation
by: Thomas Nguyen, et al.
Published: (2024-05-01)

Ablation outcomes and quality of life in patients with atrial flutter and concomitant paroxysmal atrial fibrillation
by: Anastasia Aker, et al.
Published: (2024-03-01)

Prognostic Implications and Efficacy of Catheter Ablation by Atrial Fibrillation Type
by: Hiroshi Miyama, et al.
Published: (2023-09-01)

Novel Ablation Catheters for Atrial Fibrillation
by: Iwanari Kawamura, et al.
Published: (2024-05-01)

Epigenetic regulation on left atrial function and disease recurrence after catheter ablation in atrial fibrillation
by: Mi-Ryung Han, et al.
Published: (2024-12-01)

Research Progress of Perioperative Symptoms and Management Strategies in Patients Undergoing Catheter Ablation for Atrial Fibrillation
by: BAO Zhipeng, LI Yunxia, WANG Jie, TANG Zhijie, YOU Zhanhong, HE Ying, SUN Guozhen
Published: (2025-04-01)

Recurrent atrial flutter after radiofrequency ablation for atrial fibrillation in a patient with hypertrophic obstructive cardiomyopathy undergoing repetitive transcoronary ablation of septal hypertrophy
by: Li Cheng, et al.
Published: (2024-10-01)

A novel approach to terminate roof-dependent atrial flutter with epicardial conduction through septopulmonary bundle
by: Dongchen Zhou, et al.
Published: (2024-07-01)

Effects of antiarrhythmic drug responsiveness and diagnosis‐to‐ablation time on outcomes after catheter ablation for persistent atrial fibrillation
by: Hong‐Ju Kim, et al.
Published: (2024-08-01)

Clinical and pathophysiologic determinants of catheter ablation outcome in hypertrophic cardiomyopathy with atrial fibrillation
by: Jae‐Hyuk Lee, et al.
Published: (2024-06-01)

Is it time to shorten the blanking period after atrial fibrillation ablation procedures?
by: Gerald V. Naccarelli
Published: (2025-04-01)

COMPARISON RESULTS OF THE INTRACARDIAC ELECTROPHYSIOLOGICAL STUDY IN PATIENTS WITH TYPICAL ATRIAL FLUTTER AND FIBRILLATION
by: P. S. Novikov, et al.
Published: (2017-08-01)

The impact of right atrial volume on ablation outcomes in patients with pulmonary hypertension and atrial flutter
by: Lei Ding, et al.
Published: (2024-10-01)

The association between hyperuricemia and atrial fibrillation recurrence after catheter ablation
by: Hirotsuna Oseto, et al.
Published: (2024-06-01)

Catheter ablation for non-paroxysmal atrial fibrillation. A review
by: Sabri Hassouna, et al.
Published: (2024-03-01)

Impact of pulmonary artery pressure on recurrence after catheter ablation in patients with atrial fibrillation
by: Yun Young Choi, et al.
Published: (2023-09-01)

Factors predicting the recurrence of atrial fibrillation after catheter ablation: A review
by: Degang Mo, et al.
Published: (2024-07-01)

Atrial fibrillation and flutter – the unsolved problem of medicine
by: A. G. Pronin, et al.
Published: (2024-09-01)

Excess Bed Days and Hospitalization Costs Associated With 30‐Day Complications Following Catheter Ablation of Atrial Fibrillation
by: Linh Ngo, et al.
Published: (2023-12-01)

Relief of persistent atypical atrial flutter: experience with the use of niferidil
by: E. A. Zakharyan, et al.
Published: (2023-03-01)

Clinical Characteristics and Rhythm Outcomes in Patients With Atrial Myopathy After Successful Catheter Ablation of Atrial Fibrillation
by: Moon‐Hyun Kim, et al.
Published: (2024-02-01)